These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 330776)

  • 1. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
    Braude AI; Ziegler EJ; Douglas H; McCutchan JA
    J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiserum treatment of gram-negative bacteremia.
    Braude AI; Ziegler EJ; McCutchan JA
    Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization against nosocomial infection.
    Braude AI; Ziegler EJ; McCutchan JA; Douglas H
    Am J Med; 1981 Feb; 70(2):463-6. PubMed ID: 7008592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
    Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
    N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5.
    Dunn DL; Ferguson RM
    Surgery; 1982 Aug; 92(2):212-9. PubMed ID: 7048594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of meningococcal endotoxin by antibody to core glycolipid.
    Davis CE; Ziegler EJ; Arnold KF
    J Exp Med; 1978 Apr; 147(4):1007-17. PubMed ID: 418134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of heparin in guinea pig gram negative bacterial sepsis.
    Dunn DL; Mach PA; Cerra FB; Ferguson RM
    J Surg Res; 1983 May; 34(5):479-85. PubMed ID: 6405100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
    Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI
    J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum.
    Ziegler EJ; McCutchan JA; Douglas H; Braude AI
    Trans Assoc Am Physicians; 1975; 88():101-8. PubMed ID: 772922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of antibody against "core" glycolipid of Enterobacteriaceae.
    Young LS; Stevens P; Ingram J
    J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of pretreatment with Escherichia coli J5 antiserum on guinea pig gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Dalmasso AP; Ferguson RM; Cerra FB
    J Surg Res; 1985 Mar; 38(3):298-304. PubMed ID: 3884902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.
    Bhattacharjee AK; Opal SM; Palardy JE; Drabick JJ; Collins H; Taylor R; Cotton A; Cross AS
    J Infect Dis; 1994 Sep; 170(3):622-9. PubMed ID: 8077720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.
    Ziegler EJ; McCutchan JA; Braude AI
    Eur J Cancer (1965); 1979; 15 Suppl():71-6. PubMed ID: 397063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5].
    Xu XN; Li ZJ; Li YP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):358-60. PubMed ID: 15182450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.
    Sakulramrung R; Domingue GJ
    J Infect Dis; 1985 Jun; 151(6):995-1004. PubMed ID: 3889175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immunization with Escherichia coli J5 on graft-versus-host disease induced by minor histocompatibility antigens in mice.
    Moore RH; Lampert IA; Chia Y; Aber VR; Cohen J
    Transplantation; 1987 Aug; 44(2):249-53. PubMed ID: 3307049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia.
    McCutchan JA; Wolf JL; Ziegler EJ; Braude AI
    Schweiz Med Wochenschr Suppl; 1983; 14():40-5. PubMed ID: 6361990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.